Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T cell receptor beta variable 6-1 (TRBV6-1) is a protein-coding gene segment encoding the variable region of the beta chain of the human T cell receptor (TCR)[4]. TRBV6-1 is one of many variable (V) gene segments that, through somatic V(D)J recombination in developing T cells, create the antigen-binding diversity necessary for recognition of peptide-major histocompatibility complex (pMHC) antigens on antigen-presenting cells[4][3]. The alpha-beta T cell receptor is a heterodimer essential for adaptive immune response, facilitating recognition of pathogenic and abnormal self antigens[3][4]. Upon binding its cognate pMHC, the TCR initiates intracellular signaling via CD3 subunits, leading to T cell activation, proliferation, and effector function[3][4]. TRBV6-1 does not represent a therapeutic target for small-molecule drugs but is a biomarker for analyzing T cell repertoire diversity and clonality in contexts such as infection, cancer, and autoimmune disease[4][3]. Changes in TRBV6-1 usage may be observed in immune monitoring studies, but this gene segment is not the target of any approved drugs or direct therapies at present[4][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell receptor beta variable 6-1 (TRBV6-1).